Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Atekka is a new generation agricultural insurance company.
IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.
Semnur Pharmaceuticals is a specialty pharmaceutical company focusing on clinical and commercial development of innovative products.
Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.
Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.
Serán Bioscience is a contract development and manufacturing organization.
RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.
Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.
Expedition Therapeutics develops treatments for COPD and other inflammatory respiratory diseases.
A private biopharmaceutical company .
Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.
Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.
Telum Therapeutics is a biotechnology company that develops antimicrobial therapies to combat multidrug-resistant bacterial infections.
Ocelot Bio brings new treatment options to patients with severe liver disease.
Swift Health Systems is a stealth stage start-up medical device company, developing INBRACE.
Inspirna is a biotechnology company developing drugs for the treatment of cancer.
Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.
Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
OCI develops therapies for leukaemia based on CAR–T.
IGM Biosciences is a biotechnology company that develops medicine for people with infectious infections, autoimmune diseases, and cancer.
Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.
Mereo is a new UK-based speciality biopharmaceutical company.
Vivo Capital has invested in 167 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Vivo Capital's top investment sectors include Biotechnology, Health Care, Therapeutics, Life Science, Pharmaceutical. The firm invests across 23 different industry categories.
Among tracked funding rounds, Celcuity received $500.0M in a Post-IPO Debt round. Vivo Capital's total known invested capital is $15.9B.
Vivo Capital's average investment size is $125.1M across its portfolio of 167 companies.
Recent Vivo Capital portfolio additions include Atekka, IO Biotech, Semnur Pharmaceuticals, Ventyx Biosciences, Allakos. These companies were founded in 2020 or later.